Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination — Worldwide, 2000–2018
Authors:
- Gavin B. GrantGGGavin B. Grant
- Shalini DesaiSDShalini Desai
- Laure DumolardLDLaure Dumolard
- Katrina KretsingerKKKatrina Kretsinger
- Susan E. ReefSRSusan E. Reef
- 4 October 2019
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 68 (39) , 855-859
Abstract
Progress toward rubella elimination has resulted in 168 (87%) of 194 countries protecting infants with rubella-containing vaccine and 81 (42%) eliminating rubella transmission.Keywords
This publication has 5 references indexed in Scilit:
- Accelerating measles and rubella elimination through research and innovation – Findings from the Measles & Rubella Initiative research prioritization process, 2016Vaccine, 2019
- Global landscape of measles and rubella surveillanceVaccine, 2018
- Progress in Rubella and Congenital Rubella Syndrome Control and Elimination — Worldwide, 2000–2016MMWR. Morbidity and Mortality Weekly Report, 2017
- Elimination of Rubella and Congenital Rubella Syndrome in the AmericasThe Journal of Infectious Diseases, 2011
- Rubella vaccines: WHO position paper.2011